『New concept PPI esoprazole capsule 20mg released』
KyungDong Pharm Co., Ltd. will release Esoprazole Capsule 20mg, a lower-dose product of Esoprazole Capsule 40mg, which was launched in July of last year, on June 1.
Esomeprazole, the main ingredient in esoprazole capsules, is widely known to have the strongest effect on suppressing gastric acid secretion among existing PPI agents, and is the ingredient that maintains the stomach pH above 4 for the longest time.
In addition, Esoprazole Capsule 20mg and 40mg released by KyungDong Pharm Co., Ltd. is a ‘base-free Esomeprazole’ that has removed the base of the existing original product, and is KyungDong Pharm Co., Ltd.’s third improved new drug product.
Esoprazole Capsule 40mg, which was launched last year, is a product that has been consistently prescribed since its launch, and the release of Esoprazole Capsule 20mg, a low-content product, is expected to lead to more prescriptions.
♠ Product Information ♠
▷ Product name: Esoprazole capsule 20mg
▷ Ingredient content: Esomeprazole 20mg (Esomeprazole 20 mg)
▷ Efficacy and dosage
- Treatment of erosive esophagitis: 40 mg once a day, 4 weeks
- Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once a day
- Symptomatic treatment for gastroesophageal reflux disease without esophagitis: 20 mg once a day
- 3-drug therapy for H. pylori eradication: 2 times a day, 20 mg once, 7 days
- Short-term treatment for upper gastrointestinal symptoms related to NSAIDs administration: 20 mg once a day for 4 weeks
- Treatment of gastric ulcers related to NSAIDs administration: once a day, 20 mg once a time for 4 to 8 weeks
- Prevention of gastric and duodenal ulcers related to NSAIDs administration: once a day, 20 mg per time
▷ Insurance drug price: 983 won/capsule
▷ Insurance code: 648103070
▷ Packaging unit: 28 capsules
* For further details, please refer to the product manual.